WO2010091223A1 - Biphasic collagen membrane or capsule for guided tissue regeneration - Google Patents
Biphasic collagen membrane or capsule for guided tissue regeneration Download PDFInfo
- Publication number
- WO2010091223A1 WO2010091223A1 PCT/US2010/023275 US2010023275W WO2010091223A1 WO 2010091223 A1 WO2010091223 A1 WO 2010091223A1 US 2010023275 W US2010023275 W US 2010023275W WO 2010091223 A1 WO2010091223 A1 WO 2010091223A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- membrane
- collagen
- porosity
- mold
- alcohol
- Prior art date
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 91
- 108010035532 Collagen Proteins 0.000 title claims abstract description 91
- 229920001436 collagen Polymers 0.000 title claims abstract description 91
- 239000012528 membrane Substances 0.000 title claims abstract description 80
- 230000002051 biphasic effect Effects 0.000 title claims abstract description 23
- 239000002775 capsule Substances 0.000 title description 34
- 230000017423 tissue regeneration Effects 0.000 title description 16
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 29
- 239000000725 suspension Substances 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000011148 porous material Substances 0.000 claims description 9
- 239000000835 fiber Substances 0.000 claims description 8
- 238000005266 casting Methods 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000005507 spraying Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 2
- 238000007710 freezing Methods 0.000 claims 1
- 230000008014 freezing Effects 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 description 34
- 239000000463 material Substances 0.000 description 28
- 210000001519 tissue Anatomy 0.000 description 19
- 239000012620 biological material Substances 0.000 description 11
- 230000001172 regenerating effect Effects 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 238000000605 extraction Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 230000011164 ossification Effects 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 4
- 238000007605 air drying Methods 0.000 description 4
- 239000002639 bone cement Substances 0.000 description 4
- 230000001497 fibrovascular Effects 0.000 description 4
- 238000001291 vacuum drying Methods 0.000 description 4
- 230000003416 augmentation Effects 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000010478 bone regeneration Effects 0.000 description 3
- 239000004568 cement Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 239000004053 dental implant Substances 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 230000013011 mating Effects 0.000 description 3
- 238000007711 solidification Methods 0.000 description 3
- 230000008023 solidification Effects 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000002449 bone cell Anatomy 0.000 description 2
- 239000000501 collagen implant Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 210000004373 mandible Anatomy 0.000 description 2
- 210000002050 maxilla Anatomy 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 210000004663 osteoprogenitor cell Anatomy 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical group COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 229940102838 methylmethacrylate Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/044—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/146—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B1/00—Layered products having a non-planar shape
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B1/00—Layered products having a non-planar shape
- B32B1/08—Tubular products
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
- B32B5/02—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by structural features of a fibrous or filamentary layer
- B32B5/06—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by structural features of a fibrous or filamentary layer characterised by a fibrous or filamentary layer mechanically connected, e.g. by needling to another layer, e.g. of fibres, of paper
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
- B32B5/14—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by a layer differing constitutionally or physically in different parts, e.g. denser near its faces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
- B32B5/18—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by features of a layer of foamed material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1348—Cellular material derived from plant or animal source [e.g., wood, cotton, wool, leather, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
- Y10T428/1372—Randomly noninterengaged or randomly contacting fibers, filaments, particles, or flakes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
- Y10T428/1376—Foam or porous material containing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
- Y10T428/139—Open-ended, self-supporting conduit, cylinder, or tube-type article
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
- Y10T428/1397—Single layer [continuous layer]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
- Y10T428/24942—Structurally defined web or sheet [e.g., overall dimension, etc.] including components having same physical characteristic in differing degree
Definitions
- the present invention relates to a biphasic collagen membrane for guided tissue regeneration in a human or other mammal.
- Collagen has been used as an implantable biomaterial for more than 50 years.
- the collagen used for biomedical implants is either derived from animals (e.g., cows, pigs, horses) and humans, or it is manufactured in vitro using recombinant engineering. It is known to be biocompatible and is resorbed and remodeled like natural tissues, via cellular and enzymatic processes.
- Conventional collagen implants typically have been made of highly porous, reconstituted bovine (i.e., cow) collagen. These collagen implants are commercially sold to surgeons as rectilinear sheets with uniform thicknesses and porosity. Their low density and high porosity make these collagen membranes supple and conformable. Unfortunately they therefore have inadequate tensile strength and stiffness, particularly after wetting with saline or blood, for use as a containment device in surgical applications.
- Bone is the body's primarily structural tissue; consequently it can fracture and biomechanically fail. Fortunately, it has a remarkable ability to regenerate because bone tissue contains stem cells which are stimulated to form new bone within bone tissue and adjacent to the existing bone. Boney defects regenerate from stem cells residing in viable bone, stimulated by signally proteins, and multiplying on existing cells or on an extracellular matrix (i.e., trellis). Like all tissues, bone requires support via the vascular system to supply nutrients and cells, and to remove waste. Bone will not regenerate without prompt regeneration of new blood vessels (i.e., neovascularization), typically with the first days and weeks of the regenerative cascade.
- new blood vessels i.e., neovascularization
- the present invention provides a sheet or membrane of resorbable collagen which may be used by surgeons as an implantable medical device to aid in a variety of tissue regenerative indications.
- sheets or membranes of collagen have been either highly porous and biomechanically weak or they have been minimally porous and biomechanically strong.
- High strength and stiff collagen provides structure for containing or retaining cells, growth factors or particulate matrices; however low porosity precludes the ingrowth of blood vessels and regenerative cells.
- Highly porous collagen permits essential ingrowth but does not contain or retain cells, growth factors or particulate matrices at a targeted location.
- the present invention provides a resorbable biomaterial for guided tissue regeneration which is biphasic, with selected areas designed for high strength and other areas designed for high porosity.
- the invention thus provides a biocompatible and resorbable collagen membrane, sheet or capsule with biphasic collagen for guided tissue regeneration which is ideal for many bone reconstructive indications.
- the membranes or sheets of the invention serve four functions. First, they serve as a trellis for tissue regeneration. Second, they serve as a barrier for separating tissues. Third, they serve as a biocompatible structural material for containing biomaterials at a desired location and/or in a desired configuration. Fourth, they serve as load bearing materials, typically in tension.
- Trellises of porous biomaterials serve as a framework on which and through which tissue can grow. Most tissues, including bone, proliferate only by attaching to a structure or matrix. Cells then multiply and expand on pre-existing cells, extra-cellular matrix or biomaterials. Therefore, these matrices must have porosity. However, porosity generally decreases strength, typically non-linearly such that a small amount of porosity disproportionally decreases mechanical properties. The optimal porosity has been characterized in the musculoskeletal, field, for various principal regenerative tissues. For neovascular tissue (i.e., new blood vessels), pore diameters must be larger than 20 micrometers. For osteoid (non-mineralized bone), pore diameters must be larger than 50 micrometers. For bone formation, pore diameters must be larger than 100 micrometers.
- Tissue regeneration is a race between competing tissues. Whichever tissue fills the space first, will dominate. Fibrovascular tissues proliferate faster than bone tissue. Consequently, fibrovascular tissue can preferentially fill in a defect where bone is desired, resulting in scar tissue.
- the present inventors have discovered that a membrane of collagen according to the invention can block the fibrovascular tissue, giving more time for bone formation to occur. Therefore, by using biocompatible, resorbable membranes according to the present invention as barriers to tissue regeneration, bone surgeons can exclude fibrovascular (i.e., scar tissue) from bone defects.
- the use of strategically shaped and implanted membranes according to the present invention facilitates precise placement of implanted biomaterials and enables containment or retention of the implanted biomaterial at the desired location within the body.
- the present invention makes use of collagen as a resorbable biomaterial for implantable medical devices to aid in tissue regeneration and repair. Depending on the extent of cross linking, collagen biomaterials can be manufactured to resorb over a prescribed range, typically from 6 weeks to one year.
- the present invention uses collagen membranes with three dimensional shapes to facilitate tissue regeneration, particularly bone.
- These three dimensional shapes are manufactured by casting collagen in male and female molds and lyophilizing, to form a highly porous structure. The collagen membranes are then collapsed and cross linked to provide high strength, stiff membranes.
- Collagen membranes can be formed into a variety of three dimensional shapes, such as capsules, wedges or balloons.
- capsules can be formed to contain and retain bone grafting materials to their desired location. These capsules can aid in the reconstruction of the buccal plate after tooth extraction.
- Early models of such capsules were monophasic.
- the capsules must have adequate porosity for ingrowth of blood vessels and bone cells. To provide pores for neovascular ingrowth, in some instances it has been necessary for a surgeon to intra-operatively cut and shape the membranes. This shaping is time consuming, inaccurate and compromising to mechanical function (i.e., graft containment) of the three dimensional shapes.
- the present invention solves this need by providing biphasic collagen membranes for guided tissue regeneration.
- the biphasic collagen membranes or capsules for guided tissue regeneration in accordance with the present invention may be produced by the following processes.
- Three dimension shapes of collagen membranes can be manufactured by a casting process using male/female molds. The space between the molds is filled with a collagen suspension. Macroscopic holes can be made in the membrane with strategically placed pins transecting the mold cavity. After lyphilization, the pins are removed and the mold is decoupled. The membrane can then be rehydrated and dried to provide a high strength three dimensional form. This process provides membranes with one portion of the surface contains transmembrane, unidirectional holes and another portion without porosity, but with high strength and stiffness.
- Three dimension shapes of collagen membranes can be manufacturing using male/female molds and the following penetration process.
- the space between the molds is filled with a collagen suspension.
- the membrane can then be rehydrated and dried to provide a high strength three dimensional form.
- Macroscopic holes can then be made in the membrane with strategically placed pins, cuts, or laser cutting. This process provides membranes in which one portion of the surface contains transmembrane, unidirectional holes and another portion is free of porosity, but exhibits high strength and stiffness.
- Biphasic collagen membranes can also be made by a selective rehydration/drying process.
- Three dimension shapes of collagen membrane are first manufactured using male/female molds by filling the space between the molds with collagen suspension. After lyphilization, a selected portion of the porous membrane is rehydrated and dried to provide a high strength three dimensional form. The remaining portion that is not rehyd rated/dried retains an open porosity, but has a lower strength and stiffness. This process provides membranes with one portion of the membrane contains interconnected porosity with relatively low stiffness and another portion of the membrane has high stiffness and low porosity.
- the biphasic collagen membrane or capsule of the invention has a number of important advantages for guided tissue regeneration.
- the membrane or capsule of the invention exhibits optimal porosity.
- the membrane or capsule of the invention assures that the optimal porosity is provided in collagen membranes to assure neovascular ingrowth and bone cell ingrowth because pores of the required dimensions are precisely manufactured.
- the biphasic collagen membrane or capsule of the invention also exhibits optimal strength.
- the membrane or capsule of the invention assures that the optimal mechanical properties are provided in collagen membranes so that they will deposit bone graft materials at the optimal location at retain the deposited materials at that location.
- the biphasic collagen membrane or capsule of the invention also provides convenience for the surgeon who uses it. Although a surgeon could make holes in conventional collagen membranes, the precision and continuity of the holes in the membrane or capsule of the invention would be difficult for a surgeon to replicate with typical surgical tools. Moreover, if the surgeon attempts to form perforations in the membrane, the membranes may be excessively cut or penetrated to an extent that causes it to lose the desired mechanical attributes (i.e., graft containment, tissue separation). In addition, operating time by the surgeon and staff is conserved by using the biphasic membranes of the invention.
- the biphasic membrane of the invention also has the advantage that infection rates are decreased because excessive handling of the biomaterial and excessive shaping/cutting time is eliminated.
- lyphilization refers to "freeze drying” or vacuum drying.
- the a molded collagen suspension is placed in a freezer and then a vacuum is applied. Under vacuum, the water within the collagen moves directly from the solid phase to the gas phase. Consequently, there is no shrinking or change to the dimensions. This makes a highly porous, but relatively weak collagen structure.
- a key step in the production process according to the invention is then to lightly wet the porous collagen with water which collapses the porosity. The material is then air dried. This makes a much stronger/stiffer collagen membrane. Air drying also crosslinks some of the collagen molecules to further increase the strength and decrease the resorption rate.
- Fig. 1 is an illustration of a biphasic collagen socket capsule according to the present invention for use in repair of a buccal plate after tooth extraction; and Fig. 2 is an enlarged illustration of the biphasic collagen socket capsule of Fig.
- FIGS 1 and 2 show a socket capsule according to the invention constructed of biphasic collagen for guided tissue regeneration in order to repair a buccal plate after tooth extraction.
- the buccal plate often becomes a thin layer of bone, particularly on the exterior surface (i.e., lip side) of the mandible or maxilla where it meets the teeth. If a natural tooth must be extracted because of a functional or cosmetic deviance, it may be replaced with a dental implant. Often, this buccal plate fractures during extraction or is resorbed.
- Dental implants require bone insertion depth to biologically anchor the metal surface into the mandible or maxilla. This biological process is called osteointegration. After tooth extraction, the surgeon must regenerate the amount of bone in the extraction socket and in buccal plate to at least the minimum depth to provide adequate osteointegration of the dental implant.
- a capsule of relatively stiff, high density, low porosity collagen is ideal for containing bone grafting material and placing into the socket of an extracted tooth.
- the capsule restrains the bone grafting material to exactly the correct location for maximum bone formation.
- the low porosity of a capsule made of conventional collagen material may impede bone formation because bone formation requires neovascular ingrowth and osteoprogenitor cells from outside the capsule and the low porosity collagen material may act as a barrier against neovascular growth and migration of osteoprogenitor cells.
- capsules of bovine, Type 2 collagen were manufactured which are biphasic.
- the completed capsules are shown in Figs. 1 and 2.
- the capsule can be filled with bone graft material such as autograft, allograft, growth factors, or ceramic particles.
- the apical portion and lingual side are formed with a matrix of perforations which give these regions a high porosity for facilitating neovascular ingrowth.
- the buccal portion has high stiffness to retain the bone graft material crestally.
- the biphasic collagen capsules for guided tissue regeneration according to the invention were produced as follows:
- the first step is casting the basic capsule.
- a 10-60 mg/ml suspension of purified collagen in 5-25% alcohol/water is formed.
- a particularly preferred suspension contains 15 mg of collagen per ml of a 10% solution of ethanol in water.
- the collagen fibers preferably have a native fibrous structure and a length of from 0.2 to 3 mm, particularly preferably about 1.5 mm.
- a fixed amount of the suspension is poured into a mold comprised of mating male and female mold members which form a mold cavity between them. The mold cavity is completely filled with the collagen suspension, and the main frame of the mold is tightly attached to the elastic surface of bottom plate.
- a plurality of pins are then strategically extended through the female mold into the male mold.
- pins serve as spacers for making the transmembrane, unidirectional holes in the membrane. Sufficient number of pins are placed to provide adequate neovascular ingrowth without compromising stiffness or strength.
- the pins may be arranged in any desired pattern which will produced the desired porosity. In the illustrated embodiment shown in the Figures, the pins are arranged in a generally rectangular array, but numerous other arrangement are also possible.
- the filled mold was then placed in -70 0 C freezer. After solidification of the collagen matrix, the pins were removed from the molds. Then one of the two vertical plates holding the frozen collagen was removed. The other vertical plate was also removed with the collagen on it. The plate with the frozen collagen was subsequently freeze-dried in a freeze-dryer.
- the dried collagen was removed from the Freeze-dryer and sprayed with an alcohol solution.
- a preferred alcohol solution will contain 40 to 70% alcohol.
- a particularly preferred solution contains about 50% alcohol.
- the collagen material was then subjected to air drying followed by vacuum drying. The material was then heated at 100 to 140 0 C for from 15 minutes to 2 hours. A preferred heat treatment is effected at 130 0 C for 30 minutes. The heat treated collagen membrane was then removed and cut to the desired size.
- the first step is casting the basic capsule.
- a 10-60 mg/ml suspension of purified collagen in 5-25% alcohol/water is formed.
- a particularly preferred suspension contains 15 mg of collagen per ml of a 10% solution of ethanol in water.
- the collagen fibers preferably have a native fibrous structure and a length of from 0.2 to 3 mm, particularly preferably about 1.5 mm.
- a fixed amount of the suspension is poured into a mold comprised of mating male and female mold members which form a mold cavity between them. The mold cavity is completely filled with the collagen suspension, and the main frame of the mold is tightly attached to the elastic surface of bottom plate.
- the filled mold was then placed in -70 0 C freezer. After solidification of the collagen matrix, the pins were removed from the molds. Then one of the two vertical plates holding the frozen collagen was removed. The other vertical plate was also removed with the collagen on it. The plate with the frozen collagen was subsequently freeze-dried in a freeze-dryer.
- the dried collagen was removed from the Freeze-dryer and sprayed with an alcohol solution.
- a preferred alcohol solution will contain 40 to 70% alcohol.
- a particularly preferred solution contains about 50% alcohol.
- the collagen material was then subjected to air drying followed by vacuum drying. The material was then heated at 100 to 140 0 C for from 15 minutes to 2 hours. A preferred heat treatment is effected at 130 0 C for 30 minutes.
- the heat treated collagen membrane was then removed and cut to the desired size. Holes are then made in the membrane with strategically placed pins. The pins make the transmembrane, unidirectional holes in the membrane. Sufficient number of pins are placed to provide adequate neovascular ingrowth without compromising stiffness or strength.
- the pins may be arranged in any desired pattern which will produced the desired porosity. In the illustrated embodiment shown in the Figures, the pins are arranged in a generally rectangular array, but numerous other arrangement are also possible.
- the first step is casting the basic capsule.
- a 10-60 mg/ml suspension of purified collagen in 5-25% alcohol/water is formed.
- a particularly preferred suspension contains 15 mg of collagen per ml of a 10% solution of ethanol in water.
- the collagen fibers preferably have a native fibrous structure and a length of from 0.2 to 3 mm, particularly preferably about 1.5 mm.
- a fixed amount of the suspension is poured into a mold comprised of mating male and female mold members which form a mold cavity between them. The mold cavity is completely filled with the collagen suspension, and the main frame of the mold is tightly attached to the elastic surface of bottom plate.
- the filled mold was then placed in -70 0 C freezer. After solidification of the collagen matrix, the pins were removed from the molds. Then one of the two vertical plates holding the frozen collagen was removed. The other vertical plate was also removed with the collagen on it. The plate with the frozen collagen was subsequently freeze-dried in a freeze-dryer. The dried collagen was removed from the Freeze-dryer and selected areas thereof were sprayed with an alcohol solution.
- a preferred alcohol solution will contain 40 to 70% alcohol.
- a particularly preferred solution contains about 50% alcohol.
- the areas that need to be high porosity are protected during the spraying operation.
- the collagen material was then subjected to air drying followed by vacuum drying. The material was then heated at 100 to 140 0 C for from 15 minutes to 2 hours. A preferred heat treatment is effected at 130 0 C for 30 minutes. The heat treated collagen membrane was then removed and cut to the desired size.
- the resulting capsule has areas of high tensile strength corresponding to the areas sprayed with the alcohol solution and other areas of lower tensile strength and higher porosity corresponding to the areas protected against spraying with the alcohol solution.
- the sprayed areas have a tensile strength of approximately 3600 g/mm 2 (35 MPa), a tensile modulus of approximately 95,000 g/mm 2 (932 MPa), pore diameters of less than 50 microns, and a porosity of less than 20%.
- the protected areas have a tensile strength of only about 35 g/mm 2 (0.34 MPa), a tensile modulus of approximately 560 g/mm 2 (5.5 MPa), pore diameters of greater than 50 microns, and a porosity of more than 50%.
- a material may be introduced in interior of the collagen capsule or balloon and allow the material to migrate from the inside to the outside.
- An example of having a material move from the inside to the outside is bone cement.
- Bone cement is a methyl-methacrylate based, non-resorbable biomaterial used to fix hip and knee metal implants.
- a large hole is made in the vertebral body with a removable, standard rubber balloon, similar to an angioplasty balloon or a sinus balloon.
- Bone cement is then injected into the hole to fix the fracture.
- An application of the biphasic collagen balloon is to be able to direct the location of the cement.
- the cement may selectively penetrate through the holes, particularly where it is weaker than the less porous areas to make adhesive contact with the surrounding bone tissue at specifically desired locations.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mechanical Engineering (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Materials Engineering (AREA)
- Composite Materials (AREA)
- Urology & Nephrology (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10739146.8A EP2393523A4 (en) | 2009-02-06 | 2010-02-05 | Biphasic collagen membrane or capsule for guided tissue regeneration |
US13/148,261 US20120141707A1 (en) | 2009-02-06 | 2010-02-05 | Biphasic Collagen Membrane or Capsule for Guided Tissue Regeneration |
BRPI1008524-6A BRPI1008524A2 (en) | 2009-02-06 | 2010-02-05 | "biocompatible resorbable biphasic collagen membrane and its production method" |
US14/082,035 US9833544B2 (en) | 2009-02-06 | 2013-11-15 | Biphasic collagen membrane or capsule for guided tissue regeneration |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15055509P | 2009-02-06 | 2009-02-06 | |
US61/150,555 | 2009-02-06 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/148,261 A-371-Of-International US20120141707A1 (en) | 2009-02-06 | 2010-02-05 | Biphasic Collagen Membrane or Capsule for Guided Tissue Regeneration |
US14/082,035 Continuation US9833544B2 (en) | 2009-02-06 | 2013-11-15 | Biphasic collagen membrane or capsule for guided tissue regeneration |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010091223A1 true WO2010091223A1 (en) | 2010-08-12 |
Family
ID=42542386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/023275 WO2010091223A1 (en) | 2009-02-06 | 2010-02-05 | Biphasic collagen membrane or capsule for guided tissue regeneration |
Country Status (4)
Country | Link |
---|---|
US (2) | US20120141707A1 (en) |
EP (1) | EP2393523A4 (en) |
BR (1) | BRPI1008524A2 (en) |
WO (1) | WO2010091223A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2473134A1 (en) * | 2009-09-04 | 2012-07-11 | David Cheung | High strength, high stiffness, reconstituted collagen membranes for biomedical implantation |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010117766A1 (en) * | 2009-03-30 | 2010-10-14 | Osseous Technologies Of America | Collagen biomaterial wedge |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2936229A (en) * | 1957-11-25 | 1960-05-10 | Metallizing Engineering Co Inc | Spray-weld alloys |
US3422181A (en) * | 1966-05-23 | 1969-01-14 | American Cyanamid Co | Method for heat setting of stretch oriented polyglycolic acid filament |
US3428584A (en) * | 1965-07-15 | 1969-02-18 | Gulf General Atomic Inc | Freeze-dried membrane and method of treating same |
US4624673A (en) * | 1982-01-21 | 1986-11-25 | United States Medical Corporation | Device system for dental prosthesis fixation to bone |
US5162506A (en) * | 1988-06-01 | 1992-11-10 | Natural Resources (Manufacturing) Limited | Process for preparing collagen fibers from tissue |
US5512291A (en) * | 1992-01-13 | 1996-04-30 | Li; Shu-Tung | Method of making resorbable vascular wound dressing |
US5997896A (en) * | 1995-06-07 | 1999-12-07 | Organogenesis, Inc. | Reconstituted collagen fiber segment compositions and methods of preparation thereof |
US20020119437A1 (en) * | 2000-09-20 | 2002-08-29 | Grooms Jamie M. | Method of preparing and processing transplant tissue |
US20050096734A1 (en) * | 2003-10-31 | 2005-05-05 | Majercak David C. | Implantable valvular prosthesis |
US7112417B2 (en) * | 1999-06-30 | 2006-09-26 | Ethicon, Inc. | Foam composite for the repair or regeneration of tissue |
US20080206297A1 (en) * | 2007-02-28 | 2008-08-28 | Roeder Ryan K | Porous composite biomaterials and related methods |
US20080262630A1 (en) * | 2005-10-13 | 2008-10-23 | Synthes (U.S.A. | Drug-Impregnated Encasement |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10237531A1 (en) * | 2002-08-16 | 2004-02-26 | Tutogen Medical Gmbh | implant |
US4657548A (en) * | 1984-09-11 | 1987-04-14 | Helitrex, Inc. | Delivery system for implantation of fine particles in surgical procedures |
US5711969A (en) * | 1995-04-07 | 1998-01-27 | Purdue Research Foundation | Large area submucosal tissue graft constructs |
US20030203008A1 (en) * | 1997-01-13 | 2003-10-30 | Subramanian Gunasekaran | Preparation of collagen |
US20050186283A1 (en) * | 1997-10-10 | 2005-08-25 | Ed. Geistlich Soehne Ag Fuer Chemistrie Industrie | Collagen carrier of therapeutic genetic material, and method |
HUP0402316A3 (en) * | 2001-08-21 | 2005-06-28 | Becker & Co Naturinwerk | Multi-perforated collagen film |
CA2637450A1 (en) * | 2006-01-31 | 2007-08-09 | Cook Biotech Incorporated | Fistula grafts and related methods and systems for treating fistulae |
US20080103505A1 (en) * | 2006-10-26 | 2008-05-01 | Hendrik Raoul Andre Fransen | Containment device for site-specific delivery of a therapeutic material and methods of use |
-
2010
- 2010-02-05 EP EP10739146.8A patent/EP2393523A4/en not_active Withdrawn
- 2010-02-05 BR BRPI1008524-6A patent/BRPI1008524A2/en not_active IP Right Cessation
- 2010-02-05 US US13/148,261 patent/US20120141707A1/en not_active Abandoned
- 2010-02-05 WO PCT/US2010/023275 patent/WO2010091223A1/en active Application Filing
-
2013
- 2013-11-15 US US14/082,035 patent/US9833544B2/en not_active Expired - Fee Related
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2936229A (en) * | 1957-11-25 | 1960-05-10 | Metallizing Engineering Co Inc | Spray-weld alloys |
US3428584A (en) * | 1965-07-15 | 1969-02-18 | Gulf General Atomic Inc | Freeze-dried membrane and method of treating same |
US3422181A (en) * | 1966-05-23 | 1969-01-14 | American Cyanamid Co | Method for heat setting of stretch oriented polyglycolic acid filament |
US4624673A (en) * | 1982-01-21 | 1986-11-25 | United States Medical Corporation | Device system for dental prosthesis fixation to bone |
US5162506A (en) * | 1988-06-01 | 1992-11-10 | Natural Resources (Manufacturing) Limited | Process for preparing collagen fibers from tissue |
US5512291A (en) * | 1992-01-13 | 1996-04-30 | Li; Shu-Tung | Method of making resorbable vascular wound dressing |
US5997896A (en) * | 1995-06-07 | 1999-12-07 | Organogenesis, Inc. | Reconstituted collagen fiber segment compositions and methods of preparation thereof |
US7112417B2 (en) * | 1999-06-30 | 2006-09-26 | Ethicon, Inc. | Foam composite for the repair or regeneration of tissue |
US20020119437A1 (en) * | 2000-09-20 | 2002-08-29 | Grooms Jamie M. | Method of preparing and processing transplant tissue |
US20050096734A1 (en) * | 2003-10-31 | 2005-05-05 | Majercak David C. | Implantable valvular prosthesis |
US20080262630A1 (en) * | 2005-10-13 | 2008-10-23 | Synthes (U.S.A. | Drug-Impregnated Encasement |
US20080206297A1 (en) * | 2007-02-28 | 2008-08-28 | Roeder Ryan K | Porous composite biomaterials and related methods |
Non-Patent Citations (1)
Title |
---|
See also references of EP2393523A4 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2473134A1 (en) * | 2009-09-04 | 2012-07-11 | David Cheung | High strength, high stiffness, reconstituted collagen membranes for biomedical implantation |
EP2473134A4 (en) * | 2009-09-04 | 2013-01-30 | David Cheung | High strength, high stiffness, reconstituted collagen membranes for biomedical implantation |
Also Published As
Publication number | Publication date |
---|---|
BRPI1008524A2 (en) | 2015-08-25 |
EP2393523A4 (en) | 2014-03-19 |
US9833544B2 (en) | 2017-12-05 |
US20120141707A1 (en) | 2012-06-07 |
EP2393523A1 (en) | 2011-12-14 |
US20140072747A1 (en) | 2014-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8353967B2 (en) | Self-supporting collagen tunnel for guided tissue regeneration and method of using same | |
US20120135376A1 (en) | Collagen Biomaterial Wedge | |
US8183041B2 (en) | Method of tissue repair using a multi-layered matrix | |
US6911202B2 (en) | Cosmetic repair using cartilage producing cells and medical implants coated therewith | |
JP5086642B2 (en) | Bioabsorbable plug implant and method for bone tissue regeneration | |
TW200304368A (en) | Surgical implant | |
US20050191748A1 (en) | Filamentary means for introducing agents into tissue of a living host | |
JP2007530202A (en) | Method of manufacturing bioactive prosthetic device for bone tissue regeneration and prosthetic device | |
CN112587729B (en) | Bone repair material | |
EA005322B1 (en) | Method and device for producing biological tissue in a growth chamber | |
US9833544B2 (en) | Biphasic collagen membrane or capsule for guided tissue regeneration | |
KR101754342B1 (en) | Member of 3-dimensional cartilage-culture and apparatus of cartilage-culture having the same | |
US10994050B2 (en) | High yield and high precision bone graft substitute from stem cells | |
JP4279233B2 (en) | Sheet for inducing mesenchymal tissue regeneration and method for producing the same | |
AU771161B2 (en) | Filamentary means for introducing agents into tissue of a living host | |
RU86455U1 (en) | BIO ENGINEERING DESIGN | |
CN112618798A (en) | Preparation method of bone repair material | |
WO2011028977A1 (en) | High strength, high stiffness, reconstituted collagen membranes for biomedical implantation | |
Hönig et al. | Scientific foundation significance of the periosteum in onlay craniofacial augmentation | |
CN115154674B (en) | 3D biological printing bone-like tissue engineering scaffold based on bone-like organ | |
RU2734756C2 (en) | Method for elimination of defects and deformations of lower jaw | |
Rizzi | Personalized valvular tissue engineering: a scaled up recellularization procedure to produce functional tissue for living aortic valve substitutes | |
Mahanani et al. | The proper design of scaffold porosity for bone regeneration (literature review) | |
TW202233260A (en) | Multi-layered collagen structure | |
JP2004073290A (en) | Method and member for reproducing articular cartilage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10739146 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010739146 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13148261 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: PI1008524 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: PI1008524 Country of ref document: BR Kind code of ref document: A2 Effective date: 20110804 |